BioCryst Pharmaceuticals | Obroty

Sales Zmiana Data
Alnylam Pharmaceuticals USD 494.33M 54.61M 2024-03
Chugai Pharma JPY 236.95B 36.86B 2024-03
Daiichi Sankyo JPY 409.62B 37.3B 2024-03
DBV Technologies USD 2.18M 68K 2023-09
Gilead Sciences USD 7.12B 64M 2023-12
GlaxoSmithKline GBP 7.36B 692M 2024-03
Glaxosmithkline GBP 8.05B 95M 2023-12
Incyte USD 880.89M 132.45M 2024-03
Intra Cellular Therapies USD 144.84M 12.74M 2024-03
Ionis Pharmaceuticals USD 119M 206M 2024-03
Neurocrine Biosciences USD 515.3M 100K 2024-03
PTC Therapeutics USD 210.12M 96.94M 2024-03
Regeneron Pharmaceuticals USD 3.15B 284.3M 2024-03
Roche Holding CHF 28.94B 842M 2023-12
Sarepta Therapeutics USD 413.5M 16.72M 2024-03
Ultragenyx Pharmaceutical USD 108.8M 18.59M 2024-03
Vertex Pharmaceuticals USD 2.69B 172.3M 2024-03



BioCryst Pharmaceuticals Obroty - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2024.